EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus

Ann R Falsey iD, Edward E Walsh, Stacey L House, Yannick Vandendijck iD, Marita Stevens iD, Eric K H Chan, Gabriela Ispas

Influenza and Other Respiratory Viruses · 2024

DOI: 10.1111/irv.13275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Ann R Falsey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Rochester, Rochester, New York, USA. Hauptthemen laut MEDLINE: Metapneumovirus, Severity of Illness Index, Respiratory Tract Infections, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Pharmaceuticals, Janssen Pharmaceutica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Influenza, respiratory syncytial virus (RSV), and human metapneumovirus (hMPV) are common respiratory viruses causing similar symptoms. Optimal tools to assess illness severity for these viruses have not been defined. Using the Hospitalized Acute Respiratory Tract Infection (HARTI) study data, we report symptom severity by clinician‐rated clinical severity scores (CSS) in adults with influenza, RSV, or hMPV and correlations between CSS and patient‐reported outcomes (PROs).

Methods

HARTI was a global epidemiologic study in adults hospitalized with acute respiratory tract infections. Patients were assessed at enrollment within 24 h of admission with CSS and twice during hospitalization with CSS, Respiratory Infection Intensity and Impact Questionnaire™ (RiiQ™), and EQ‐5D‐5L. Data were summarized descriptively, stratified by pathogen and baseline and hospitalization characteristics. Domain (general, upper respiratory, and lower respiratory) and sign/symptom subscores are presented for CSS; sign/symptom subscores are presented for RiiQ™ results.

Results

Data from 635 patients with influenza, 248 with RSV, and 107 with hMPV were included. At enrollment, total CSS and general and lower respiratory signs/symptoms (LRS) scores were higher for RSV and hMPV than influenza. Between‐pathogen differences were greatest for LRS scores. Dyspnea, rales/rhonchi, wheezing, and shortness of breath scores trended higher for RSV and hMPV than influenza. RiiQ™ scores for cough, fatigue, and short of breath were strongly correlated with corresponding clinician‐rated symptoms.

Conclusions

These findings support the use of PROs (e.g., the RiiQ™) correlating with clinician assessments to gauge patient well‐being and aid patient management by accurately assessing respiratory illness severity due to RSV, hMPV, or influenza.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetapneumovirusSeverity of Illness IndexRespiratory Tract InfectionsRespiratory Syncytial Virus InfectionsInfluenza, HumanHospitalizationParamyxoviridae InfectionsHumansMaleFemaleMiddle AgedAdultAgedYoung AdultRespiratory Syncytial Virus, HumanAged, 80 and overAdolescent

Stichwörter der Autor:innen

HARTIRSVhMPVhospitalizationhuman metapneumovirusinfluenzapatient‐reported outcomesrespiratory syncytial virus

Autor:innen und Institutionen

  • Department of Medicine, University of Rochester, Rochester, New York, USA.
  • Department of Emergency Medicine, School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Janssen Research & Development, Beerse, Belgium.
  • Janssen Global Services, LLC, Raritan, New Jersey, USA.
  • Janssen Global Medical Affairs Infectious Diseases & Vaccines, Beerse, Belgium.

ORCID-Profile: Ann R Falsey, Yannick Vandendijck, Marita Stevens

Förderung

  • Janssen Pharmaceuticals
  • Janssen Pharmaceutica

Zitieren

APA

Falsey, A. R., Walsh, E. E., House, S. L., Vandendijck, Y., Stevens, M., Chan, E. K. H., & Ispas, G. (2024). Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13275

Vancouver

Falsey AR, Walsh EE, House SL, Vandendijck Y, Stevens M, Chan EKH, et al. Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.13275

BibTeX
@article{Falsey2024,
  author = {Falsey, Ann R and Walsh, Edward E and House, Stacey L and Vandendijck, Yannick and Stevens, Marita and Chan, Eric K H and Ispas, Gabriela},
  title = {Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2024},
  doi = {10.1111/irv.13275}
}
Kostenlos starten →